UPDATE 2-U.S. judge in Texas invalidates Allergan patents on Restasis
15 Oct UPDATE 2-U.S. judge in Texas invalidates Allergan patents on Restasis
Posted at 18:12h
in
News
by KMFSLLP
Oct 16 (Reuters) – A U.S. judge invalidated patents on
Allergan Plc’s dry eye medicine Restasis on the grounds
that the patents cover obvious ideas, a decision that drove the
pharmaceutical company’s shares down more than 6 percent.
No Comments